Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Neoplasm by Morphology — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology

Other

Neoplasm by Morphology

CI-CAN-00000002Explore in graph →

Non-malignant13,311 active trials222 approved drugs2,774 evidence items

NCIt: C4741

Overview
Statistics
Survival
Genomics449
Variants & evidence2774
Drugs319
Trials52642
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

52,642 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Completed 20,424 Recruiting 8,893 Unknown 7,825 Terminated 5,723 Active Not Recruiting 4,223 Not Yet Recruiting 2,790 Withdrawn 1,995 Suspended 268 Enrolling By Invitation 250 No Longer Available 129 Approved For Marketing 61 Available 56 Temporarily Not Available 5

PhaseAll Early Phase 1 972 N/A 6,669 Phase 1 13,345 Phase 2 22,268 Phase 3 4,995 Phase 4 858

No study matches these filters